Investor Relations

Reports & SEC Filings

View all Company SEC Filings (EDGAR), click here

Latest Reports

Our reporting periods are:

  • FY Q1: Sept - Nov
  • FY Q2: Dec - Feb
  • FY Q3: Mar - May
  • FY Annual: Sept - Aug

Presentations

SEC Filings

View all Company SEC Filings (EDGAR), click here

Copy of Annual Reports

Upon request, a hardcopy of the Company's annual report is available free of charge.
Please contact us to request: Contact

Stay connected with Investor news

Follow us and stay up to date on what's happening at Novo Integrated Sciences

CAUTION CONCERNING FORWARD LOOKING STATEMENTS
Novo Integrated Sciences's Investor Relations website at www.novointegrated.com/investors and our corporate blog at novointegrated.com/newsroom as well as Novo Integrated Sciences's social media accounts, contain a significant amount of information about the company, including financial and other information for investors. Novo Integrated Sciences encourages investors to visit these websites from time to time, as information is updated and new information is posted.

avatar

Robert Mattacchione

CEO, Novo Integrated Sciences

Follow Robert on LinkedIn


avatar

Chris David

COO, Novo Integrated Sciences

Follow Chris on LinkedIn


Follow Us

Company

Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the Nasdaq Capital Markets (Nasdaq:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada.

Site Map
Address

Copyright © 2000 - 2021 Novo Integrated Sciences Inc. All rights reserved